Staccato Apomorphine Single and Multi Dose PK
NCT03822364
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
56
Enrollment
UNKNOWN
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
009-1
DRUG:
active comparator
DRUG:
009-0
DRUG:
009-2
DRUG:
009-3
DRUG:
009-4
DRUG:
009-5
Sponsor
Alexza Pharmaceuticals, Inc.